Hydrogel-embeded vesicles, as a novel approach for prolonged release and delivery of liposome, in vitro and in vivo

Journal of Liposome Research

Volumn 23, Issue 3, 2013, Pages 235-243

  Alinaghi, A ^a   Rouini, M R ^a   Johari Daha, F ^b   Moghimi, H R ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ATOMIC ENERGY ORGANIZATION OF IRAN   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

in situ forming liposomal hydrogel; Intraperitoneal injection; Radiolabel liposomes; Tissue distribution

Indexed keywords

CHITOSAN; GLYCEROPHOSPHATE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LIPOSOME;

ARTICLE; BLOOD; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG RELEASE; FEMALE; GASTROINTESTINAL TRACT; GELATION; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; INTEGRATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TEMPERATURE; TISSUES;

ANIMALS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; HYDROGELS; LIPOSOMES; MICE; MONONUCLEAR PHAGOCYTE SYSTEM; PERITONEAL CAVITY; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TISSUE DISTRIBUTION;

EID: 84880489683     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2013.799179     Document Type: Article

References (38)

1. Abashzadeh SH, Dinarvand R, Sharifzade M, et al. (2011). Formulation and evaluation of an in situ gel forming system for controlled delivery of triptorelin acetate. Eur J Pharm Sci 44:514-52.
2. Ahmadi R, de Bruijin JD. (2008). Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels. J Biomed Mater Res A 86: 824-32.
3. Awasthi VD, Garcia D, Goins BA, Phillips WT. (2003). Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Inter J Pharm 253:121-32.
4. Bajaj G, Ran Kim M, Mohammed SI, Yeo Y. (2012). Hyaluronic acidbased hydrogel for regional delivery of paclitaxel to intraperitoneal tumors. J Control Rel 158:386-92.
5. Boerman OC, Laverman P, Oyen WJG, et al. (2000). Radiolabeled liposomes for scintigraphic imaging. Prog Lipid Res 39:461-75.
6. Chenite A, Buschmann MD, Wang D, et al. (2001). Rheological characterisation of thermogelling chitosan-glycerolphosphate solution. Carbohydr Polym 46:39-47.
7. Chung TW, Yang MC, Tsai WJ. (2006). A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs: influences of the surface properties of liposomes and the crosslinked fibrin network. Int J Pharm 311:122-9.
8. Chung YM, Simmons KL, Gutowska A, Jeong B. (2002). Sol-gel transition temperature of PLGA-g-PEG aqueous solutions. Biomacromolecules 3:511-16.
9. Furumoto K, Yokoe JI, Ogawara KI, et al. (2007). Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int J Pharm 329:110-16.
10. Goins BA, Klipper R, Rudolph AS, Phillips WT. (1994). Use of technetium-99m-liposomes in tumor imaging. J Nucl Med 35:1491-8.
11. Gong CY, Shia S, Wu L, et al. (2009). Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: Sol-gel-sol transition and drug delivery behavior. Acta Biomater 5:3358-70.
12. Han HD, Lee A, Hwang T, Song CK. (2007). Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes. J Control Rel 120:161-8.
13. Hosny KM. (2010). Ciprofloxacin as ocular liposomal hydrogel. AAPS Pharm Sci Tech 11:241-6.
14. Hurler J, Berg OA, Skar M, et al. (2012). Improved burns therapy: liposome in hydrogel delivery system for mupirocin. J Pharm Sci 101: 3906-15.
15. Laverman P, Dams ETM, Oyen WJG, et al. (1999). A novel method to label liposomes with Tc-99m by the hydrazino nicotinyl derivative. J Nucl Med 40:192-7.
16. Liu L, Tang X, Wang Y, Guo S. (2011). Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery system. Int J Pharm 414:6-15.
17. Mirahmadi N, Babaei MH, Vali AM, et al. (2008). 99mTc-HMPAO labeled liposomes: an investigation into the effects of some formulation factors on labeling efficiency and in-vitro stability. Nucl Med Biol 35:387-92.
18. Mirahmadi N, Babaei MH, Vali AM, Dadashzadeh S. (2010). Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice. Int J Pharm 383:7-13.
19. Moghimi SM, Szebeni J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463-78.
20. Mufamadi MS, Pillay V, Choonara YE, Du Toit LC. (2011). A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv 2011:1-19.
21. Mulik R, Kulkarni V, Murthy RSP. (2009). Chitosan-based thermosensitive hydrogel containing liposomes for sustained delivery of cytarabine. Drug Dev Ind Pharmacy 35:49-56.
22. Neirinckx RD, Canning LR, Piper IM, et al. (1987). Technetium-99m d, l-HMPAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191-202.
23. Oussoren C, Eling WM, Crommelin DJ, et al. (1998). The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim Biophys Acta 1369:159-72.
24. Pavelić Z,Skalko-Basnet N, Schubert R (2001). Liposomal gels for vaginal drug delivery. Int J Pharm, 219, 139-49.
25. Peschka R, Dennehy R, Szoka Jr FC. (1998). A simple in vitro model to study the release kinetics of liposome encapsulated material. J Control Rel 56:41-51.
26. Phillips WT. (1999). Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev 37:13-32.
27. Phillips WT, Medina LA, Klipper R, Goins B. (2002). A novel approach for the increased delivery of pharmaceutical agents to peritoneum and associated lymph nodes. J Pharmacol Exp Ther 303:11-16.
28. Phillips WT, Rudolph AS, Goins B, et al. (1992). A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Int J Radiat Appl Instrum B 19:539-47.
29. Polozova A, Li X, Shangguan T, Meers P. (2005). Formation of homogeneous unilamellar liposomes from an interdigitated matrix. Biochim Biophys Acta 1668:117-25.
30. Prekeges J. (2010). Factors relating to radiation measurement. In: Gartside M, ed. Nuclear Medicine Instrumentation. Massachusetts: Jones and Bartlett Publishers, 36-49.
31. Ruel-Gariepy E, Leclair G, Hildgen P, et al. (2002). Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Rel 82:373-83.
32. Song F, Zhang L, Yang C, Yan L. (2009). Genipin-crosslinked casein hydrogels for controlled drug delivery. Int J Pharm 373:41-7.
33. Stenekes RJH, Loebis AE, Fernandes CM, et al. (2000). Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. Pharm Res 17:690-5.
34. Stewart JC. (1980). Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10-14.
35. Szebeni J, Baranyi L, Savay S, et al. (2000). The role of complement activation in hypersensitivity to pegylated liposomal doxorubicin (Doxil-). J Liposome Res 10:467-81.
36. Yokoe JI, Sakuragia S, Yamamoto K. (2008). Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats. Int J Pharm 353:28-34.
37. Zhang HH, Luo QH, Yang ZJ, et al. (2011). Novel ophthalmic timolol liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo. Drug Deliv 18:502-10.
38. Zuidam NJ, Versluis C, Vernooy EA, Crommelin DJ. (1996). Gamma-irradiation of liposomes composed of saturated phospholipids: effect of bilayer composition, size, concentration and absorbed dose on chemical degradation and physical destabilization of liposomes. Biochim Biophys Acta 3:135-48.